BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17525900)

  • 1. Management of bleeding complications of hematologic malignancies.
    Green D
    Semin Thromb Hemost; 2007 Jun; 33(4):427-34. PubMed ID: 17525900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion therapy in acquired coagulopathies.
    Humphries JE
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1181-201. PubMed ID: 7860444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acquired coagulation disorders in emergency and intensive-care medicine.
    Staudinger T; Locker GJ; Frass M
    Semin Thromb Hemost; 1996; 22(1):93-104. PubMed ID: 8711494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory evaluation of a bleeding patient.
    Wallerstein RO
    West J Med; 1989 Jan; 150(1):51-8. PubMed ID: 2660407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
    Tallman MS; Kwaan HC
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Children with hemorrhagic diathesis: correct diagnostic and therapeutic approach].
    Carnelli V; Dozzi M; Gibelli M; Giovanniello A; Riva F; Seidita C; Stucchi C
    Pediatr Med Chir; 1990; 12(1):1-13. PubMed ID: 2198546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic complications in leukemic patients.
    Goodnight SH
    Geriatrics; 1978 Mar; 33(3):53-7. PubMed ID: 564314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic abnormalities associated with cancer and its therapy.
    Glassman AB
    Ann Clin Lab Sci; 1997; 27(6):391-5. PubMed ID: 9433535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies.
    Castaman G; Bona ED; Schiavotto C; Trentin L; D'Emilio A; Rodeghiero F
    Haematologica; 1997; 82(5):584-7. PubMed ID: 9407726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhagic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):408-15. PubMed ID: 17525898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombelastography monitoring of platelet substitution therapy and rFVIIa administration in haemato-oncological patients with severe thrombocytopenia.
    Salaj P; Marinov I; Marková M; Pohlreich D; Cetkovský P; Hrachovinová I
    Prague Med Rep; 2004; 105(3):311-7. PubMed ID: 15782557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation disorders in the ICU.
    Marks PW
    Clin Chest Med; 2009 Mar; 30(1):123-9, ix. PubMed ID: 19186284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired bleeding disorders: bleeding in obstetrics and surgery.
    Bonnar J
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():10-2. PubMed ID: 7886547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.